{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T19:06:06Z","timestamp":1787339166587,"version":"build-2736575974"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s10787-021-00815-w","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T12:03:19Z","timestamp":1620820999000},"page":"661-672","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Infliximab prevents systemic bone loss and suppresses tendon inflammation in a collagen-induced arthritis rat model"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4840-9748","authenticated-orcid":false,"given":"Frideriki","family":"Poutoglidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chryssa","family":"Pourzitaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Eleni","family":"Manthou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthimios","family":"Samoladas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Saitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foteini","family":"Malliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Kouvelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,12]]},"reference":[{"issue":"1","key":"815_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/BOR.0000000000000449","volume":"30","author":"IE Adamopoulos","year":"2018","unstructured":"Adamopoulos IE (2018) Inflammation in bone physiology and pathology. Curr Opin Rheumatol 30(1):59\u201364. https:\/\/doi.org\/10.1097\/BOR.0000000000000449","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"815_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/ard.62.4.347","volume":"62","author":"F Allali","year":"2003","unstructured":"Allali F, Breban M, Porcher R, Maillefert JF, Dougados M, Roux C (2003) Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha. Ann Rheum Dis 62(4):347\u2013349. https:\/\/doi.org\/10.1136\/ard.62.4.347","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"815_CR3","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1172\/JCI119333","volume":"99","author":"P Ammann","year":"1997","unstructured":"Ammann P, Rizzoli R, Bonjour JP, Bourrin S, Meyer JM, Vassalli P, Garcia I (1997) Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J Clin Invest 99(7):1699\u20131703. https:\/\/doi.org\/10.1172\/JCI119333","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"815_CR4","doi-asserted-by":"publisher","first-page":"i10","DOI":"10.1093\/rheumatology\/keaa039","volume":"59","author":"EG Araujo","year":"2020","unstructured":"Araujo EG, Schett G (2020) Enthesitis in psoriatic arthritis (Part 1): pathophysiology. Rheumatology (oxford) 59(Suppl 1):i10\u2013i14. https:\/\/doi.org\/10.1093\/rheumatology\/keaa039","journal-title":"Rheumatology (oxford)"},{"issue":"7","key":"815_CR5","doi-asserted-by":"publisher","first-page":"4858","DOI":"10.1074\/jbc.275.7.4858","volume":"275","author":"Y Azuma","year":"2000","unstructured":"Azuma Y, Kaji K, Katogi R, Takeshita S, Kudo A (2000) Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J Biol Chem 275(7):4858\u20134864. https:\/\/doi.org\/10.1074\/jbc.275.7.4858","journal-title":"J Biol Chem"},{"issue":"10","key":"815_CR6","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1002\/jor.20674","volume":"26","author":"MF Barbe","year":"2008","unstructured":"Barbe MF, Elliott MB, Abdelmagid SM, Amin M, Popoff SN, Safadi FF, Barr AE (2008) Serum and tissue cytokines and chemokines increase with repetitive upper extremity tasks. J Orthop Res 26(10):1320\u20131326. https:\/\/doi.org\/10.1002\/jor.20674","journal-title":"J Orthop Res"},{"key":"815_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/1471-2474-14-303","volume":"14","author":"MF Barbe","year":"2013","unstructured":"Barbe MF, Gallagher S, Massicotte VS, Tytell M, Popoff SN, Barr-Gillespie AE (2013) The interaction of force and repetition on musculoskeletal and neural tissue responses and sensorimotor behavior in a rat model of work-related musculoskeletal disorders. BMC Musculoskelet Disord 14:303. https:\/\/doi.org\/10.1186\/1471-2474-14-303","journal-title":"BMC Musculoskelet Disord"},{"key":"815_CR8","unstructured":"Bendele A (2001) Animal models of rheumatoid arthritis. J Musculoskelet Neuronal Interact 1(4):377\u2013385. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15758488"},{"issue":"1","key":"815_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.pharep.2014.08.009","volume":"67","author":"SE Bilasy","year":"2015","unstructured":"Bilasy SE, Essawy SS, Mandour MF, Ali EA, Zaitone SA (2015) Myelosuppressive and hepatotoxic potential of leflunomide and methotrexate combination in a rat model of rheumatoid arthritis. Pharmacol Rep 67(1):102\u2013114. https:\/\/doi.org\/10.1016\/j.pharep.2014.08.009","journal-title":"Pharmacol Rep"},{"issue":"5","key":"815_CR10","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/nprot.2007.173","volume":"2","author":"DD Brand","year":"2007","unstructured":"Brand DD, Latham KA, Rosloniec EF (2007) Collagen-induced arthritis. Nat Protoc 2(5):1269\u20131275. https:\/\/doi.org\/10.1038\/nprot.2007.173","journal-title":"Nat Protoc"},{"issue":"5","key":"815_CR11","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1177\/0300985815588612","volume":"52","author":"P Caplazi","year":"2015","unstructured":"Caplazi P, Baca M, Barck K, Carano RA, DeVoss J, Lee WP, Bolon B, Diehl L (2015) Mouse models of rheumatoid arthritis. Vet Pathol 52(5):819\u2013826. https:\/\/doi.org\/10.1177\/0300985815588612","journal-title":"Vet Pathol"},{"issue":"2","key":"815_CR12","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/1756-185X.13238","volume":"21","author":"DY Chen","year":"2018","unstructured":"Chen DY, Lau CS, Elzorkany B, Hsu PN, Praprotnik S, Vasilescu R, Marshall L, Llamado L (2018) Dosing down and then discontinuing biologic therapy in rheumatoid arthritis: a review of the literature. Int J Rheum Dis 21(2):362\u2013372. https:\/\/doi.org\/10.1111\/1756-185X.13238","journal-title":"Int J Rheum Dis"},{"key":"815_CR13","doi-asserted-by":"publisher","first-page":"945945","DOI":"10.1155\/2013\/945945","volume":"2013","author":"A Corrado","year":"2013","unstructured":"Corrado A, Neve A, Maruotti N, Cantatore FP (2013) Bone effects of biologic drugs in rheumatoid arthritis. Clin Dev Immunol 2013:945945. https:\/\/doi.org\/10.1155\/2013\/945945","journal-title":"Clin Dev Immunol"},{"issue":"7","key":"815_CR14","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","volume":"73","author":"M Cross","year":"2014","unstructured":"Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, Williams B, Gabriel S, Lassere M, Johns N, Buchbinder R, Woolf A, March L (2014) The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 73(7):1316\u20131322. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204627","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"815_CR15","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s10103-016-1918-7","volume":"31","author":"GF Da Re","year":"2016","unstructured":"Da Re GF, Vieira CP, Oliveira LP, Marques PP, dos Santos AM, Pimentel ER (2016) Low-level laser therapy modulates pro-inflammatory cytokines after partial tenotomy. Lasers Med Sci 31(4):759\u2013766. https:\/\/doi.org\/10.1007\/s10103-016-1918-7","journal-title":"Lasers Med Sci"},{"issue":"3","key":"815_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10067-012-2128-8","volume":"32","author":"G Dischereit","year":"2013","unstructured":"Dischereit G, Tarner IH, Muller-Ladner U, Lange U (2013) Infliximab improves bone metabolism and bone mineral density in rheumatoid arthritis and ankylosing spondylitis: a prospective 2-year study. Clin Rheumatol 32(3):377\u2013381. https:\/\/doi.org\/10.1007\/s10067-012-2128-8","journal-title":"Clin Rheumatol"},{"issue":"10","key":"815_CR17","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.3899\/jrheum.121417","volume":"40","author":"A Durnez","year":"2013","unstructured":"Durnez A, Paternotte S, Fechtenbaum J, Landewe RB, Dougados M, Roux C, Briot K (2013) Increase in bone density in patients with spondyloarthritis during anti-tumor necrosis factor therapy: 6-year followup study. J Rheumatol 40(10):1712\u20131718. https:\/\/doi.org\/10.3899\/jrheum.121417","journal-title":"J Rheumatol"},{"issue":"5","key":"815_CR18","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jbspin.2017.11.014","volume":"85","author":"E Ebstein","year":"2018","unstructured":"Ebstein E, Coustet B, Masson-Behar V, Forien M, Palazzo E, Dieude P, Ottaviani S (2018) Enthesopathy in rheumatoid arthritis and spondyloarthritis: an ultrasound study. Joint Bone Spine 85(5):577\u2013581. https:\/\/doi.org\/10.1016\/j.jbspin.2017.11.014","journal-title":"Joint Bone Spine"},{"issue":"2","key":"815_CR19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1148\/radiology.202.2.9015088","volume":"202","author":"K Ecklund","year":"1997","unstructured":"Ecklund K, Laor T, Goorin AM, Connolly LP, Jaramillo D (1997) Methotrexate osteopathy in patients with osteosarcoma. Radiology 202(2):543\u2013547. https:\/\/doi.org\/10.1148\/radiology.202.2.9015088","journal-title":"Radiology"},{"issue":"5","key":"815_CR20","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/rheumatology\/32.5.387","volume":"32","author":"F Eggelmeijer","year":"1993","unstructured":"Eggelmeijer F, Papapoulos SE, Westedt ML, Van Paassen HC, Dijkmans BA, Breedveld FC (1993) Bone metabolism in rheumatoid arthritis; relation to disease activity. Br J Rheumatol 32(5):387\u2013391. https:\/\/doi.org\/10.1093\/rheumatology\/32.5.387","journal-title":"Br J Rheumatol"},{"key":"815_CR21","doi-asserted-by":"publisher","first-page":"3830212","DOI":"10.1155\/2020\/3830212","volume":"2020","author":"Q Fang","year":"2020","unstructured":"Fang Q, Zhou C, Nandakumar KS (2020) Molecular and cellular pathways contributing to joint damage in rheumatoid arthritis. Mediators Inflamm 2020:3830212. https:\/\/doi.org\/10.1155\/2020\/3830212","journal-title":"Mediators Inflamm"},{"issue":"8","key":"815_CR22","doi-asserted-by":"publisher","first-page":"e71875","DOI":"10.1371\/journal.pone.0071875","volume":"8","author":"HG Gao","year":"2013","unstructured":"Gao HG, Fisher PW, Lambi AG, Wade CK, Barr-Gillespie AE, Popoff SN, Barbe MF (2013) Increased serum and musculotendinous fibrogenic proteins following persistent low-grade inflammation in a rat model of long-term upper extremity overuse. PLoS ONE 8(8):e71875. https:\/\/doi.org\/10.1371\/journal.pone.0071875","journal-title":"PLoS ONE"},{"issue":"1","key":"815_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10067-019-04771-3","volume":"39","author":"K Gulyas","year":"2020","unstructured":"Gulyas K, Horvath A, Vegh E, Pusztai A, Szentpetery A, Petho Z, Vancsa A, Bondar N, Csomor P, Hamar A, Bodoki L, Bhattoa HP, Juhasz B, Nagy Z, Hodosi K, Karosi T, FitzGerald O, Szucs G, Szekanecz Z, Szamosi S, Szanto S (2020) Effects of 1-year anti-TNF-alpha therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis. Clin Rheumatol 39(1):167\u2013175. https:\/\/doi.org\/10.1007\/s10067-019-04771-3","journal-title":"Clin Rheumatol"},{"issue":"11","key":"815_CR24","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1136\/ard.61.11.1007","volume":"61","author":"BJ Harrison","year":"2002","unstructured":"Harrison BJ, Hutchinson CE, Adams J, Bruce IN, Herrick AL (2002) Assessing periarticular bone mineral density in patients with early psoriatic arthritis or rheumatoid arthritis. Ann Rheum Dis 61(11):1007\u20131011. https:\/\/doi.org\/10.1136\/ard.61.11.1007","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"815_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10103-015-1821-7","volume":"31","author":"C Helrigle","year":"2016","unstructured":"Helrigle C, de Carvalho P, Casalechi HL, Leal-Junior EC, Fernandes GH, Helrigel PA, Rabelo RL, Aleixo-Junior IO, Albertini R (2016) Effects of low-intensity non-coherent light therapy on the inflammatory process in the calcaneal tendon of ovariectomized rats. Lasers Med Sci 31(1):33\u201340. https:\/\/doi.org\/10.1007\/s10103-015-1821-7","journal-title":"Lasers Med Sci"},{"issue":"3","key":"815_CR26","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s00113-016-0291-0","volume":"120","author":"M Henniger","year":"2017","unstructured":"Henniger M, Rehart S (2017) Tendinopathy in rheumatic diseases. Unfallchirurg 120(3):214\u2013219. https:\/\/doi.org\/10.1007\/s00113-016-0291-0","journal-title":"Unfallchirurg"},{"issue":"8","key":"815_CR27","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.3899\/jrheum.121376","volume":"40","author":"M Hoff","year":"2013","unstructured":"Hoff M, Kavanaugh A, Haugeberg G (2013) Hand bone loss in patients with psoriatic arthritis: posthoc analysis of IMPACT II data comparing infliximab and placebo. J Rheumatol 40(8):1344\u20131348. https:\/\/doi.org\/10.3899\/jrheum.121376","journal-title":"J Rheumatol"},{"issue":"3","key":"815_CR28","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.3892\/etm.2017.4817","volume":"14","author":"Y Hu","year":"2017","unstructured":"Hu Y, Yang Y, Luo B (2017) Evaluation of destruction in a collagen-induced arthritis rat model: Bony spur formation. Exp Ther Med 14(3):2563\u20132567. https:\/\/doi.org\/10.3892\/etm.2017.4817","journal-title":"Exp Ther Med"},{"issue":"6","key":"815_CR29","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00198-018-4473-1","volume":"29","author":"S Jin","year":"2018","unstructured":"Jin S, Hsieh E, Peng L, Yu C, Wang Y, Wu C, Wang Q, Li M, Zeng X (2018) Incidence of fractures among patients with rheumatoid arthritis: a systematic review and meta-analysis. Osteoporos Int 29(6):1263\u20131275. https:\/\/doi.org\/10.1007\/s00198-018-4473-1","journal-title":"Osteoporos Int"},{"issue":"2\u20133","key":"815_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10787-015-0229-0","volume":"23","author":"S Jinesh","year":"2015","unstructured":"Jinesh S (2015) Pharmaceutical aspects of anti-inflammatory TNF-blocking drugs. Inflammopharmacology 23(2\u20133):71\u201377. https:\/\/doi.org\/10.1007\/s10787-015-0229-0","journal-title":"Inflammopharmacology"},{"issue":"8","key":"815_CR31","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/jor.21079","volume":"28","author":"T John","year":"2010","unstructured":"John T, Lodka D, Kohl B, Ertel W, Jammrath J, Conrad C, Stoll C, Busch C, Schulze-Tanzil G (2010) Effect of pro-inflammatory and immunoregulatory cytokines on human tenocytes. J Orthop Res 28(8):1071\u20131077. https:\/\/doi.org\/10.1002\/jor.21079","journal-title":"J Orthop Res"},{"issue":"4","key":"815_CR32","doi-asserted-by":"publisher","first-page":"244","DOI":"10.7555\/JBR.32.20170019","volume":"33","author":"JS Kang","year":"2019","unstructured":"Kang JS (2019) Effect of methotrexate on collagen-induced arthritis in male Wistar rats. J Biomed Res 33(4):244\u2013249. https:\/\/doi.org\/10.7555\/JBR.32.20170019","journal-title":"J Biomed Res"},{"issue":"5","key":"815_CR33","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/bcpt.12037","volume":"112","author":"A Karson","year":"2013","unstructured":"Karson A, Demirtas T, Bayramgurler D, Balci F, Utkan T (2013) Chronic administration of infliximab (TNF-alpha inhibitor) decreases depression and anxiety-like behaviour in rat model of chronic mild stress. Basic Clin Pharmacol Toxicol 112(5):335\u2013340. https:\/\/doi.org\/10.1111\/bcpt.12037","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"815_CR34","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/art.39458","volume":"68","author":"AS Kehl","year":"2016","unstructured":"Kehl AS, Corr M, Weisman MH (2016) Review: enthesitis: new insights into pathogenesis, diagnostic modalities, and treatment. Arthritis Rheumatol 68(2):312\u2013322. https:\/\/doi.org\/10.1002\/art.39458","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"815_CR35","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1136\/annrheumdis-2019-216656","volume":"79","author":"A Kerschbaumer","year":"2020","unstructured":"Kerschbaumer A, Sepriano A, Smolen JS, van der Heijde D, Dougados M, van Vollenhoven R, McInnes IB, Bijlsma JWJ, Burmester GR, de Wit M, Falzon L, Landewe R (2020) Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis 79(6):744\u2013759. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216656","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"815_CR36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejr.2019.07.005","volume":"42","author":"AK Khalifa","year":"2020","unstructured":"Khalifa AK, Diab SA, Hashem GM, Alalkamy EF, Yacoub MF (2020) New promising avenue for the simvastatin combination with residronate, strontium ranelate and raloxifene in experimentally-induced osteoporosis. Egypt Rheumatol 42(1):63\u201369. https:\/\/doi.org\/10.1016\/j.ejr.2019.07.005","journal-title":"Egypt Rheumatol"},{"issue":"6","key":"815_CR37","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 8(6):e1000412. https:\/\/doi.org\/10.1371\/journal.pbio.1000412","journal-title":"PLoS Biol"},{"issue":"2","key":"815_CR38","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1084\/jem.191.2.275","volume":"191","author":"K Kobayashi","year":"2000","unstructured":"Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T (2000) Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF\/RANKL-RANK interaction. J Exp Med 191(2):275\u2013286. https:\/\/doi.org\/10.1084\/jem.191.2.275","journal-title":"J Exp Med"},{"issue":"12","key":"815_CR39","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1093\/rheumatology\/kei082","volume":"44","author":"U Lange","year":"2005","unstructured":"Lange U, Teichmann J, Muller-Ladner U, Strunk J (2005) Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study. Rheumatology (oxford) 44(12):1546\u20131548. https:\/\/doi.org\/10.1093\/rheumatology\/kei082","journal-title":"Rheumatology (oxford)"},{"key":"815_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040880","author":"YJ Lin","year":"2020","unstructured":"Lin YJ, Anzaghe M, Schulke S (2020) Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells. https:\/\/doi.org\/10.3390\/cells9040880","journal-title":"Cells"},{"issue":"12","key":"815_CR41","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1136\/ard.2003.016253","volume":"63","author":"MC Lodder","year":"2004","unstructured":"Lodder MC, de Jong Z, Kostense PJ, Molenaar ET, Staal K, Voskuyl AE, Hazes JMW, Dijkmans BAC, Lems WF (2004) Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density. Ann Rheum Dis 63(12):1576\u20131580. https:\/\/doi.org\/10.1136\/ard.2003.016253","journal-title":"Ann Rheum Dis"},{"key":"815_CR42","doi-asserted-by":"publisher","first-page":"CD000957","DOI":"10.1002\/14651858.CD000957.pub2","volume":"6","author":"MA Lopez-Olivo","year":"2014","unstructured":"Lopez-Olivo MA, Siddhanamatha HR, Shea B, Tugwell P, Wells GA, Suarez-Almazor ME (2014) Methotrexate for treating rheumatoid arthritis. Cochrane Database Syst Rev 6:CD000957. https:\/\/doi.org\/10.1002\/14651858.CD000957.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"815_CR43","doi-asserted-by":"publisher","first-page":"R253","DOI":"10.1186\/ar789","volume":"5","author":"A Machner","year":"2003","unstructured":"Machner A, Baier A, Wille A, Drynda S, Pap G, Drynda A, Mawrin C, Buhling F, Gay S, Neumann W, Pap T (2003) Higher susceptibility to Fas ligand induced apoptosis and altered modulation of cell death by tumor necrosis factor-alpha in periarticular tenocytes from patients with knee joint osteoarthritis. Arthritis Res Ther 5(5):R253-261. https:\/\/doi.org\/10.1186\/ar789","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"815_CR44","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2147\/btt.s2338","volume":"2","author":"H Marotte","year":"2008","unstructured":"Marotte H, Miossec P (2008) Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNFalpha therapy. Biologics 2(4):663\u2013669. https:\/\/doi.org\/10.2147\/btt.s2338","journal-title":"Biologics"},{"issue":"1","key":"815_CR45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3899\/jrheum.180797","volume":"47","author":"A Mourad","year":"2020","unstructured":"Mourad A, Gniadecki R (2020) Treatment of dactylitis and enthesitis in psoriatic arthritis with biologic agents: a systematic review and metaanalysis. J Rheumatol 47(1):59\u201365. https:\/\/doi.org\/10.3899\/jrheum.180797","journal-title":"J Rheumatol"},{"issue":"1","key":"815_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.joca.2005.07.014","volume":"14","author":"KP Pritzker","year":"2006","unstructured":"Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, Salter D, van den Berg WB (2006) Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage 14(1):13\u201329. https:\/\/doi.org\/10.1016\/j.joca.2005.07.014","journal-title":"Osteoarthritis Cartilage"},{"key":"815_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/0471142735.im1505s89","author":"EF Rosloniec","year":"2010","unstructured":"Rosloniec EF, Cremer M, Kang AH, Myers LK, Brand DD (2010) Collagen-induced arthritis. Curr Protoc Immunol. https:\/\/doi.org\/10.1002\/0471142735.im1505s89 (Chapter 15, Unit 15 15 11\u201325)","journal-title":"Curr Protoc Immunol"},{"issue":"5","key":"815_CR48","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.bone.2004.07.004","volume":"35","author":"N Saidenberg-Kermanac'h","year":"2004","unstructured":"Saidenberg-Kermanac\u2019h N, Corrado A, Lemeiter D, deVernejoul MC, Boissier MC, Cohen-Solal ME (2004) TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis. Bone 35(5):1200\u20131207. https:\/\/doi.org\/10.1016\/j.bone.2004.07.004","journal-title":"Bone"},{"issue":"1","key":"815_CR49","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/BF00361126","volume":"11","author":"AM Schwartz","year":"1984","unstructured":"Schwartz AM, Leonidas JC (1984) Methotrexate osteopathy. Skeletal Radiol 11(1):13\u201316. https:\/\/doi.org\/10.1007\/BF00361126","journal-title":"Skeletal Radiol"},{"key":"815_CR50","unstructured":"Sengupta P (2013) The laboratory rat: relating its age with human\u2019s. Int J Prev Med 4(6):624\u2013630. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23930179"},{"key":"815_CR51","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1196\/annals.1351.040","volume":"1069","author":"B Seriolo","year":"2006","unstructured":"Seriolo B, Paolino S, Sulli A, Ferretti V, Cutolo M (2006) Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis. Ann N Y Acad Sci 1069:420\u2013427. https:\/\/doi.org\/10.1196\/annals.1351.040","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"815_CR52","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nm.2817","volume":"18","author":"JP Sherlock","year":"2012","unstructured":"Sherlock JP, Joyce-Shaikh B, Turner SP, Chao CC, Sathe M, Grein J, Gorman DM, Bowman EP, McClanahan TK, Yearley JH, Eberl G, Buckley CD, Kastelein RA, Pierce RH, LaFace DM, Cua DJ (2012) IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+CD4-CD8- entheseal resident T cells. Nat Med 18(7):1069\u20131076. https:\/\/doi.org\/10.1038\/nm.2817","journal-title":"Nat Med"},{"issue":"3","key":"815_CR53","first-page":"224","volume":"24","author":"BR Simmen","year":"1995","unstructured":"Simmen BR, Gschwend N (1995) Tendon diseases in chronic rheumatoid arthritis. Orthopade 24(3):224\u2013236","journal-title":"Orthopade"},{"issue":"3","key":"815_CR54","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s10787-018-0541-6","volume":"27","author":"X Sun","year":"2019","unstructured":"Sun X, Wang Y, Zhang M, Wang Q (2019) Intraarticular injection of dexamethasone promotes bone erosion in collagen-induced arthritis in mice through up-regulation of RANKL expression. Inflammopharmacology 27(3):503\u2013509. https:\/\/doi.org\/10.1007\/s10787-018-0541-6","journal-title":"Inflammopharmacology"},{"issue":"Suppl 3","key":"815_CR55","doi-asserted-by":"publisher","first-page":"S217","DOI":"10.1007\/BF03194376","volume":"7","author":"Y Suzuki","year":"1997","unstructured":"Suzuki Y, Mizushima Y (1997) Osteoporosis in rheumatoid arthritis. Osteoporos Int 7(Suppl 3):S217-222. https:\/\/doi.org\/10.1007\/BF03194376","journal-title":"Osteoporos Int"},{"issue":"2","key":"815_CR56","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1365-2567.2011.03522.x","volume":"135","author":"C Tang","year":"2012","unstructured":"Tang C, Chen S, Qian H, Huang W (2012) Interleukin-23: as a drug target for autoimmune inflammatory diseases. Immunology 135(2):112\u2013124. https:\/\/doi.org\/10.1111\/j.1365-2567.2011.03522.x","journal-title":"Immunology"},{"issue":"2","key":"815_CR57","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.berh.2018.10.005","volume":"32","author":"D van der Woude","year":"2018","unstructured":"van der Woude D, van der Helm-van Mil AHM (2018) Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Pract Res Clin Rheumatol 32(2):174\u2013187. https:\/\/doi.org\/10.1016\/j.berh.2018.10.005","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"10","key":"815_CR58","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1002\/art.22117","volume":"54","author":"TP van Staa","year":"2006","unstructured":"van Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C (2006) Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 54(10):3104\u20133112. https:\/\/doi.org\/10.1002\/art.22117","journal-title":"Arthritis Rheum"},{"issue":"12","key":"815_CR59","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1111\/j.1365-2036.2011.04667.x","volume":"33","author":"SG Veerappan","year":"2011","unstructured":"Veerappan SG, O\u2019Morain CA, Daly JS, Ryan BM (2011) Review article: the effects of antitumour necrosis factor-alpha on bone metabolism in inflammatory bowel disease. Aliment Pharmacol Ther 33(12):1261\u20131272. https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04667.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"815_CR60","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1136\/ard.2007.084426","volume":"68","author":"S Visvanathan","year":"2009","unstructured":"Visvanathan S, van der Heijde D, Deodhar A, Wagner C, Baker DG, Han J, Braun J (2009) Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis. Ann Rheum Dis 68(2):175\u2013182. https:\/\/doi.org\/10.1136\/ard.2007.084426","journal-title":"Ann Rheum Dis"},{"key":"815_CR61","doi-asserted-by":"crossref","unstructured":"Zorn AM (2001) Wnt signalling: antagonistic Dickkopfs. Curr Biol 11(15):R592\u2013595. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11516963","DOI":"10.1016\/S0960-9822(01)00360-8"},{"issue":"1","key":"815_CR62","doi-asserted-by":"publisher","first-page":"R22","DOI":"10.1186\/ar1872","volume":"8","author":"J Zwerina","year":"2006","unstructured":"Zwerina J, Tuerk B, Redlich K, Smolen JS, Schett G (2006) Imbalance of local bone metabolism in inflammatory arthritis and its reversal upon tumor necrosis factor blockade: direct analysis of bone turnover in murine arthritis. Arthritis Res Ther 8(1):R22. https:\/\/doi.org\/10.1186\/ar1872","journal-title":"Arthritis Res Ther"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-021-00815-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-021-00815-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-021-00815-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T06:15:15Z","timestamp":1624601715000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-021-00815-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,12]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["815"],"URL":"https:\/\/doi.org\/10.1007\/s10787-021-00815-w","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,12]]},"assertion":[{"value":"1 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Directorate of Veterinary Services of the Region of Central Macedonia according to national legislation (Presidential Decree 56\/2013, in conformance with the European Directive (2010\/63\/EU).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}